Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Polen Capital - Global Growth 2023 Q3 Investor Letter | Buyside Digest

Back to Fund Profile (Polen Capital - Global Growth)

Primary Source Intelligence • Q3 2023 Letter Analysis

Polen Capital - Global Growth Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Polen Capital - Global Growth. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD-3.46%

YTD+17.57%

Annualized+10.28%

Positioning StanceConstructive

Market CapLarge Cap

GeographyGlobal

Digest Analysis

Quick Take

"Polen Capital's concentrated global growth strategy delivered strong year-to-date outperformance despite Q3 weakness."

Executive Summary

Polen Capital's Global Growth Portfolio declined 3.46% net in Q3 2023, in line with the MSCI ACWI, but outperformed significantly year-to-date with 17.57% returns versus 10.06% for the index. The managers maintain their focus on owning high-quality businesses through cycles, emphasizing that macro factors like Fed policy and interest rate speculation will not meaningfully impact the long-term fundamentals of their holdings. Key contributors included Alphabet, Adobe, and ADP, while LVMH, Siemens Healthineers, and Align Technology detracted. Portfolio activity included new purchases of MSCI and Novo Nordisk, with trims to Adobe, ICON, ServiceNow, and Microsoft, while adding to Workday and Amazon. The team highlighted themes around AI innovation at Alphabet and Adobe, cloud migration opportunities at Amazon, and GLP-1 drug potential at Novo Nordisk. Trading at 23x forward earnings, they expect the portfolio to deliver mid-teens earnings growth for many years, viewing current valuations as fair for what they consider some of the world's best companies.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

78%

CautiousHigh

High Conviction (78%)

High conviction evidenced by concentrated portfolio with detailed thesis explanations for each holding. Managers provide specific position sizing commentary, name individual holdings with substantive analysis, and express strong views on competitive advantages and long-term prospects.

Growth Outlook

25%

BearishBullish

Bearish (25%)

The managers acknowledge market digestion of first-half gains and Fed uncertainty but maintain a constructive long-term view. They see macro factors as short-term noise rather than fundamental threats, with confidence in their companies' ability to perform through cycles.

Risk Appetite

40%

DefensiveAggressive

Defensive (40%)

The portfolio remains fully invested with active position management, including new purchases and strategic trims. The managers are selectively adding to high-conviction names like Workday and Amazon while maintaining concentrated exposure to quality growth companies.

Capital Deployment

15%

De-riskingDeploying

De-risking (15%)

Net neutral deployment with rotation activity. The managers added two new positions (MSCI and Novo Nordisk) while trimming four others and adding to two existing holdings. This represents capital rotation rather than net new deployment or de-risking.

Forward Guidance

30%

CautiousExpansionary

Cautious (30%)

The team expresses confidence in continued execution and expects their companies to perform well through cycles. They are actively deploying capital into new names like MSCI and Novo Nordisk while optimizing position sizes across the portfolio.

Language Signal

20%

BearishBullish

Bearish (20%)

Language is balanced with acknowledgment of macro uncertainty and market volatility, but emphasizes long-term competitive advantages and growth prospects. Risk language around Fed policy and margin pressure is offset by confidence in business fundamentals.

Perceived Risk

45%

Low RiskElevated

Moderate Risk (45%)

Moderate risk acknowledgment focused on macro factors like Fed policy uncertainty and potential recession risks. The managers discuss interest rate speculation and potential economic damage from previous hikes, but frame these as short-term concerns rather than fundamental threats.

Opportunity Density

65%

ScarceAbundant

Abundant (65%)

Selective opportunities with the managers identifying specific attractive investments like MSCI at fair valuations and Novo Nordisk's GLP-1 opportunity. They demonstrate ability to find compelling ideas while maintaining selectivity in a challenging environment.

Time Horizon

75%

Short-TermLong-Term

Decade+ (75%)

Multi-year investment horizon with emphasis on owning businesses through cycles and expecting mid-teens earnings growth for many years. The managers focus on long-term competitive advantages and sustainable business models rather than near-term catalysts.